Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-09-04 8:45 pm Sale |
2024-08-30 | 13D | Tango Therapeutics, Inc. TNGX |
Third Rock Ventures IV L.P. | 17,001,475 15.900% |
-2,362,500 (-12.20%) |
Filing History |
| 2024-02-14 4:15 pm Unchanged |
2023-12-31 | 13G | Dianthus Therapeutics, Inc. DNTH |
Third Rock Ventures IV L.P. | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2022-02-14 4:53 pm Purchase |
2021-12-31 | 13G | Magenta Therapeutics, Inc. MGTA |
Third Rock Ventures IV L.P. | 6,758,204 11.500% |
6,758,204 (New Position) |
Filing History |
| 2021-08-19 4:35 pm Purchase |
2021-08-10 | 13D | Tango Therapeutics, Inc. TNGX |
Third Rock Ventures IV L.P. | 19,363,975 22.100% |
19,363,975 (New Position) |
Filing History |